Back to Ovarian Cancer
NCT00038428
NCT00038428
Who may be able to join
Who might be able to join this trial:
- You have been diagnosed with ovarian cancer, confirmed by a tissue sample or biopsy
- Your cancer has come back or has not fully gone away after your first course of treatment
- Your cancer can be measured on scans or tests
- You have previously received at least one, but no more than three, chemotherapy treatments
- Your cancer has stopped responding to, or did not respond to, platinum-based chemotherapy (a common type of chemotherapy)
- You are at least 18 years old
- You are generally well enough to carry out everyday activities with little or no limitation (confirm with trial site)
- Your liver, kidneys, and blood cell counts are within an acceptable healthy range (confirm with trial site)
Who may not be able to join:
- You are currently pregnant or breastfeeding
- You have received chemotherapy or immunotherapy within the last four weeks
- You have previously had radiation therapy covering your entire pelvic area
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Trial details
Status
Completed
Phase
Phase 2
Sponsor
Telik
Registry
clinicaltrials_gov
Start date
1 June 2001
Est. completion
1 July 2005
Where this trial is recruiting
🇺🇸 United States
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.